Moore Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-75,000
| Closed | -$491K | – | 673 |
|
|
2020
Q4 | $491K | Hold |
75,000
| – | – | 0.01% | 436 |
|
|
2020
Q3 | $499K | Hold |
75,000
| – | – | 0.01% | 299 |
|
|
2020
Q2 | $625K | Sell |
75,000
-25,000
| -25% | -$208K | 0.02% | 206 |
|
|
2020
Q1 | $767K | Hold |
100,000
| – | – | 0.03% | 128 |
|
|
2019
Q4 | $831K | Hold |
100,000
| – | – | 0.03% | 194 |
|
|
2019
Q3 | $738K | Sell |
100,000
-25,000
| -20% | -$185K | 0.03% | 220 |
|
|
2019
Q2 | $1.4M | Hold |
125,000
| – | – | 0.03% | 215 |
|
|
2019
Q1 | $1.34M | Hold |
125,000
| – | – | 0.04% | 207 |
|
|
2018
Q4 | $1.89M | Hold |
125,000
| – | – | 0.07% | 141 |
|
|
2018
Q3 | $2.31M | Buy |
+125,000
| New | +$2.31M | 0.05% | 159 |
|